Pure Biologics S.A. (WSE:PUR)
2.170
-0.010 (-0.46%)
Jun 16, 2026, 1:51 PM CET
-50.11% (1Y)
| Market Cap | 26.69M -20.9% |
| Revenue (ttm) | n/a |
| Net Income | -10.73M |
| EPS | -1.57 |
| Shares Out | 12.24M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 173,060 |
| Open | 2.190 |
| Previous Close | 2.180 |
| Day's Range | 1.972 - 2.250 |
| 52-Week Range | 1.353 - 9.200 |
| Beta | 0.25 |
| Analysts | Strong Buy |
| Price Target | 96.90 (+4,365.44%) |
| Earnings Date | Sep 30, 2026 |